Evolve Global Healthcare Enhanced Yield Fund (TSX:LIFE)
Assets | 203.83M |
Expense Ratio | 0.74% |
PE Ratio | 22.00 |
Dividend (ttm) | 2.28 |
Dividend Yield | 12.28% |
Ex-Dividend Date | Jun 30, 2025 |
Payout Frequency | Monthly |
Payout Ratio | 271.31% |
1-Year Return | -6.09% |
Volume | 4,860 |
Open | 18.56 |
Previous Close | 18.57 |
Day's Range | 18.44 - 18.56 |
52-Week Low | 17.24 |
52-Week High | 22.88 |
Beta | 1.10 |
Holdings | 95 |
Inception Date | Oct 25, 2017 |
About LIFE
Evolve Global Healthcare Enhanced Yield Fund is an exchange traded fund launched and managed by Evolve Funds Group Inc. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across health care sectors. The fund uses derivatives such as options to create its portfolio. It invests in growth and value stocks of large-cap companies. The fund seeks to track the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged. Evolve Global Healthcare Enhanced Yield Fund was formed on October 24, 2017 and is domiciled in Canada.
Performance
LIFE had a total return of -6.09% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.02%.
Top 10 Holdings
129.25% of assetsName | Symbol | Weight |
---|---|---|
Canadian Dollar | n/a | 81.74% |
Novo Nordisk A/S | NVO | 5.87% |
Boston Scientific Corporation | BSX | 5.33% |
AstraZeneca PLC | AZN | 5.32% |
Intuitive Surgical, Inc. | ISRG | 5.27% |
Novartis AG ADR | NVSN.MX | 5.22% |
Stryker Corporation | SYK | 5.17% |
Pfizer Inc. | PFE | 5.13% |
Roche Holding AG | RHHBY | 5.12% |
Gilead Sciences, Inc. | GILD | 5.08% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Jun 30, 2025 | 0.190 CAD | Jul 8, 2025 |
May 30, 2025 | 0.190 CAD | Jun 6, 2025 |
Apr 30, 2025 | 0.190 CAD | May 7, 2025 |
Mar 31, 2025 | 0.190 CAD | Apr 7, 2025 |
Feb 28, 2025 | 0.190 CAD | Mar 7, 2025 |
Jan 31, 2025 | 0.190 CAD | Feb 7, 2025 |